Rifaximin and Eluxadoline Utilization for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the United States and Budget Impact Analysis of Switching from Eluxadoline to Rifaximin
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.561
https://www.valueinhealthjournal.com/article/S1098-3015(18)30861-1/fulltext
Section Title :
Section Order :
1358
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30861-1&doi=10.1016/j.jval.2018.04.561